E
Exact Sciences Corp D
D
EXAS
51.550
USD
4.42
(9.38%)
مغلق
حجم التداول
270,796
الربح لكل سهم
-0
العائد الربحي
-
P/E
-9
حجم السوق
9,722,055,187
الأخبار المقالات
العنوان: Exact Sciences Corp
القطاع: Healthcare
الصناعة: Diagnostics & Research
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, aliquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening.